Asia Spotlight: U.S. Congressmen Call On FDA Commissioner To Press Investigation Into Adulterated Heparin During Upcoming Trip To China
Executive Summary
On the second Monday of each month, "The Pink Sheet" provides exclusive news and commentary on the Asia biopharma market from the editors of its affiliated online publication, PharmAsia News. Register at 1PAN_Trial_LP.html"http://pharmasianews.elsevierbi.com/ PAN_Trial_LP.html for a free trial.
You may also be interested in...
House Investigation Of Tainted Heparin Could Highlight Need For Import Safety Legislation - Or Not
Energy and Commerce Republicans seek to determine who contaminated heparin supplies in 2008, how they did it, and why FDA has failed to answer those questions as the panel begins oversight of the agency.
House Investigation Of Tainted Heparin Could Highlight Need For Import Safety Legislation - Or Not
Energy and Commerce Republicans seek to determine who contaminated heparin supplies in 2008, how they did it, and why FDA has failed to answer those questions as the panel begins oversight of the agency.
U.S. Congressmen Call On China To Bring To Justice Those Who Deliberately Adulterated Heparin
BEIJING - Although the case of nearly 150 patients across American hospitals who died after being given heparin that was deliberately adulterated in China two years ago had seemed to fade from front pages and some regulatory radar screens, two U.S. congressmen have been waging a vigil-like campaign for U.S. FDA leaders to press Chinese counterparts to help bring those responsible to justice